Benutzer: Gast  Login
Titel:

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.

Dokumenttyp:
Journal Article; Research Support, Non-U.S. Gov't
Autor(en):
Aubele, M; Walch, AK; Ludyga, N; Braselmann, H; Atkinson, MJ; Luber, B; Auer, G; Tapio, S; Cooke, T; Bartlett, JM
Abstract:
The cytoplasmic tyrosine kinase PTK6 (BRK) shows elevated expression in approximately two-thirds of primary breast tumours, and is implicated in EGF receptor-dependent signalling and epithelial tumorigenesis. Using immunohistochemistry, we performed a retrospective study on 426 archival breast cancer samples from patients with long-term follow-up and compared the protein expression levels of PTK6, the HER receptors, Sam68 (a substrate of PTK6), and signalling proteins including MAP kinase (MAPK), phosphorylated MAPK (P-MAPK), and PTEN. We show that PTK6 expression is of significant prognostic value in the outcome of breast carcinomas. In multivariate analysis, the disease-free survival of patients of >or=240 months was directly associated with the protein expression level of PTK6 (P
Zeitschriftentitel:
Br J Cancer
Jahr:
2008
Band / Volume:
99
Heft / Issue:
7
Seitenangaben Beitrag:
1089-95
Sprache:
eng
Volltext / DOI:
doi:10.1038/sj.bjc.6604660
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/18781181
Print-ISSN:
0007-0920
TUM Einrichtung:
Institut für Allgemeine Pathologie und Pathologische Anatomie
 BibTeX